Pub. Date : 2020 May 1
PMID : 31948999
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Recent FDA approvals of regimens targeting programmed death 1 (PD-1) in combination with anti-CTLA-4 or with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) are reshaping front-line therapy for metastatic kidney cancer. | Tyrosine | vascular endothelial growth factor A | Homo sapiens |
2 | Recent FDA approvals of regimens targeting programmed death 1 (PD-1) in combination with anti-CTLA-4 or with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) are reshaping front-line therapy for metastatic kidney cancer. | Tyrosine | vascular endothelial growth factor A | Homo sapiens |